- Casework
- Explore Utah
- Find America's Missing Children
- FirstGov
- Genealogy
- Legislative    Schedule
- Small Business


Email me
Contact Me
Text Only

En Español

Privacy Policy

US Senator Orrin Hatch
April 30th, 2002  
 
HATCH MAKES THE CASE FOR REGENERATIVE MEDICINE
 
Washington -- Sen. Orrin G. Hatch (R-Utah) today announced his support of legislation promoting regenerative medicine. His press conference statement follows:

In the weeks ahead, the United States Senate will debate an issue that is of extreme importance to millions of Americans suffering from disease. The challenge before Congress is twofold. We must craft a law to make sure that human beings are not cloned. At the same time, we must not stand in the way of scientific advances that hold the promise of treatments and cures for literally millions of Americans.

At the outset, I just want to read one letter I received from my constituents – the parents of Cody Anderson in West Jordan, Utah. This sums it up far better than I can:

Dear Senator Hatch,

We would first like to thank you for carefully studying stem cell research and coming out in favor of it last year. We appreciate your taking the correct moral stand on this very important issue. We now need you to
again lead the way on another important issue, the cloning of human cells for research to cure the diseases such as diabetes. Let us just share a little of our story of why this is so important to our family.

I would first like to start by telling you how I became familiar with diabetes. My father was diabetic from the age of seven years old and by the time I was four years old he had lost his sight. He never saw my youngest brother. As we grew up we always knew that our father was different but we learned to live with the disease. We slowly watched more complications take shape because of the disease. He eventually lost function of his kidneys and was on kidney dialysis for 10 years. He eventually lost his left leg below the knee, had two toes amputated from the right foot because of poor circulation, had a colostomy, had his left eye removed to relieve pain and pressure and in total had 28 surgeries just to keep him alive, all because of the devastating effects of the diabetes. Finally on April 29, 1991, his heart
just stopped and he died at the age of 47. The cause of death: diabetes.

I am now married and have three children of my own and my worst fears came true on June 9, 2000, when my youngest son Cody was diagnosed with diabetes at the age of 2. The same disease that I watched slowly take my father away from me at such a young age. Cody has to have his blood sugars tested at least 6-10 times daily. He is on an insulin pump and has to have his site changed 3 to 4 times a week. We have to know every bite of food that he eats and how many carbohydrates each bite has so we can figure the correct amount of insulin to give him. Every day is different depending on his activities for the day. A growth spurt can throw everything off for days at a time. Something as simple as the common cold can have devastating effects on his blood sugars. The stomach flu is also something extremely difficult
to deal with as well.

Not only does diabetes affect Cody’s life but it affects the lives of our entire family. My husband and I have to work opposite schedules just because we don’t have anyone close by that can watch Cody. Anytime Cody goes to a friend’s house for playgroup we need to be where they can reach us at all
times because they don’t understand the simple basics of taking care of a diabetic child.

With your leadership on this issue, we can help people understand that cloning human tissue for research has nothing to do with making carbon "copies of people" or creating life. It is about saving human lives and easing the pain and suffering of children like Cody.

Sincerely,

The Anderson Family

As a father of six, and a grandfather of 20, when I read that letter, it really tugged at my heartstrings. It pointed out so clearly the challenge before us: to help families like the Andersons, without sanctioning human cloning, which is anathema to us all.

And so, I am pleased today to join with my colleagues to announce agreement on legislation which we hope will do just that: prevent human beings from being cloned, but promote – with appropriate safeguards – the new science of regenerative medicine.

This is not a position that I reached easily. Indeed, my decision came after countless hours of study, reflection and prayer. I consulted as broadly as I could on this issue, talking with Americans from all walks of life, scientific experts from across the country, religious leaders and ethicists. I did all I could to make sure I understood as completely as possible all the issues at stake.

I met with proponents of this research, such as Dr. Irv Weissman, who is with us today, and with opponents, such as Dr. Leon Kass, the Chairman of the President’s Bioethics Commission. And I have great respect for the sincerity and decency of those who disagree with me.

After considerable time, thought and prayer, I believed I knew enough to make an informed decision on this issue. My study took me back to the books of the Old Testament and forward to the latest issues of the New England Journal of Medicine.

Once I identified and weighed what I considered to be the relevant factors, the decision itself was not a close call.

The first part of the legislation was easy. There is near-universal agreement that attempts to clone a baby should be stopped at all costs. This would directly interfere with God’s sacred plan for human reproduction by a man and woman within the bounds of marriage. Accordingly, our bill will criminalize any attempt to clone a human being.

The second part was the more difficult.

In addition to banning human cloning, our bill advances the field of regenerative medicine by explicitly authorizing – with appropriate safeguards – somatic cell nuclear transfer or nuclear transplantation.

Let me be clear. It was only after my colleagues agreed to include these safeguards that I agreed to cosponsor the measure. It may be that we need further clarification of these safeguards, and I intend to work with my colleagues to make any necessary changes as the bill moves forward. But, on balance, this is a bill that I can support, and I will support given its enormous importance.

We have with us today many distinguished scientists who can explain nuclear transplantation far better than I. The import of what they will say is that the process of somatic cell transfer can be used as a potential source of stem cells that are extremely useful in regenerative medicine research.

One of the goals of regenerative medicine is to learn how these undifferentiated stem cells develop into the over 200 specialized cells and tissues that comprise the human body. This knowledge could hold the key to understanding much about human health and disease and may yield new diagnostic tests and treatments to help all the Cody Andersons of the world.

That is what this bill will do — promise to help the 100 million Americans who are struggling with the day-to-day challenges of currently incurable diseases. We are talking about cancer, heart disease, diabetes, AIDS, Alzheimer’s, ALS, Parkinson’s, multiple sclerosis and so many other diseases. We are talking about our grandmothers and grandfathers, our mothers and fathers, our children and our grandchildren. We are talking about the people with whom we work and worship, our friends in the neighborhood and our colleagues at work. We are talking about each of us here in the room today.

During this debate you will hear some question whether we really need to conduct the type of research our bill authorizes. Others will try to paint the measure as pro-embryo destruction. Each of us must search our own soul to come to grips with such fundamental questions as when life begins.

We will ask our colleagues and the public to listen carefully to what leading experts in science believe. For example, a group of 40 American Nobel Prize winners have written to Congress to ask us to support this research. I will also make available today copies of a few of the compelling letters I have received from Intel CEO Andy Grove and the Director of the prestigious Huntsman Cancer Institute, Stephen Prescott. We should listen to them and to the clerical leaders and patient advocates who are with us today.

I come to this issue with a strong pro-life, pro-family record. But I also strongly believe that a critical part of being pro-life is to support measures that help the living.

Some, including many in the Right to Life community, oppose this research on the grounds that the new cell created in the laboratory becomes a new human life at the moment it is electronically activated. That is a view I respect, but with which I do not agree. At the core of my support for regenerative medicine research is my belief that human life requires and begins in a mother’s nurturing womb.

As I considered the ethical appropriateness of nuclear transplantation in regenerative medicine research, two facts stood out:

* The egg, with its nucleus removed, is never fertilized with sperm;

* The resulting unfertilized, electrically activated embryo will not be implanted into a woman’s womb so there is no chance of a birth. I should add that our bill would prevent implantation into any type of artificial womb that may one day be developed.

The absence of a fertilized egg coupled with a legal prohibition against implantation leads me to conclude that this research can be conducted, with appropriate safeguards, in an ethically proper fashion.

Should we continue other forms of stem cell research, such as adult stem cell research? Absolutely. I hope that adult stem cell research lives up to its promise. But should we cut off the promising avenue that embryonic stem cell research holds out? The answer to me is clear: no.

Americans deserve the best treatments available. To ban human somatic cell nuclear transfer research would be a tragic mistake. It could force Americans to travel abroad to seek the latest treatments. Prohibiting this research in our country could also drive many of our young, talented scientists overseas. As we have done so often in biomedical research, it is in the interest of our nation to lead the way in this new field and to help set the ethical and moral standards for the rest of the world.

Before I close, I want to recognize all the cosponsors of this important legislation. Senator Specter and our colleague, the Chairman of the Labor-HHS Appropriations Subcommittee, Tom Harkin, have held 14 hearings that have centered on the unprecedented promise of stem cell research. I am also pleased to have worked with Senators Feinstein and Kennedy in developing the legislation that is being introduced today. Along with Senator Specter, they provided leadership in this area by sponsoring earlier legislation that we build upon today.

I am particularly pleased that Senator Zell Miller joins us in this effort because he brings the level-headed, pragmatic approach that we will need in this debate. I also want to pay special recognition to Senators Brownback and Landrieu; while my conclusion ultimately differs with theirs, I respect their position and their work to bring this crucial issue to the forefront of public debate. Let us remember, we all have the same goal: we want to do what we believe in our hearts is the right thing to do. We just disagree.

Regenerative medicine is pro-life and pro-family; it enhances, not diminishes, human life. If encouraged to flourish, it can improve the lives of millions of Americans and could lead to new scientific frontiers not now in sight. I urge my colleagues in the Senate and the American public to support this bill that opposes human cloning but promotes regenerative medicine using nuclear transplantation. Thank you.

 
###
 
 
Printable Version
 
« previous Topic next Topic »